{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:18:05Z","timestamp":1792117085289,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.ajic.2006.05.238","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T14:20:53Z","timestamp":1153491653000},"page":"S20-S28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":362,"special_numbering":"S","title":["Resistance in gram-negative bacteria: Enterobacteriaceae"],"prefix":"10.1016","volume":"34","author":[{"given":"David L.","family":"Paterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2006.05.238_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2006.05.238_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","article-title":"International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections","volume":"140","author":"Paterson","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajic.2006.05.238_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003495-200363040-00002","article-title":"Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention, and drug treatment","volume":"63","author":"Rupp","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ajic.2006.05.238_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10408410490266429","article-title":"Extended-spectrum beta-lactamases (ESBLs): characterization, epidemiology, and detection","volume":"30","author":"Shah","year":"2004","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ajic.2006.05.238_bib6","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00134-002-1521-1","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome","volume":"28","author":"Du","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajic.2006.05.238_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/420816","article-title":"Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases","volume":"39","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajic.2006.05.238_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1139\/w03-111","article-title":"Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases","volume":"50","author":"Walther-Rasmussen","year":"2004","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new beta-lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2006.05.238_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/CMR.18.2.306-325.2005","article-title":"Metallo-beta-lactamases: the quiet before the storm?","volume":"18","author":"Walsh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajic.2006.05.238_bib12","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.39.5.1187","article-title":"In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins","volume":"39","author":"Jett","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib14","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib16","series-title":"Data on file. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement","year":"2005"},{"key":"10.1016\/j.ajic.2006.05.238_bib17","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1128\/AAC.47.11.3442-3447.2003","article-title":"Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study","volume":"47","author":"Zanetti","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/AAC.48.2.533-537.2004","article-title":"Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States","volume":"48","author":"Alvarez","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jac\/dki074","article-title":"Increase in AmpC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR","volume":"55","author":"Tracz","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/AAC.40.2.342","article-title":"In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins","volume":"40","author":"Martinez-Martinez","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib21","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/322667","article-title":"Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"33","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2004.08.001","article-title":"Evolution and dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997\u20132003)","volume":"51","author":"DiPersio","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib23","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1086\/429239","article-title":"Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species","volume":"40","author":"Hyle","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBLs) in the community","volume":"56","author":"Pitout","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1086\/421094","article-title":"Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes","volume":"38","author":"Pitout","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib26","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/AAC.47.7.2382-2383.2003","article-title":"Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from 5 US States","volume":"47","author":"Moland","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib27","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/AAC.47.11.3554-3560.2003","article-title":"Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from 7 countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases","volume":"47","author":"Paterson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10096-003-1084-2","article-title":"Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients","volume":"23","author":"Colodner","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib29","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dkh397","article-title":"Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK","volume":"54","author":"Munday","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","article-title":"Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients","volume":"42","author":"Rodriguez-Bano","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/dkh424","article-title":"Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK","volume":"54","author":"Woodford","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib32","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1128\/AAC.48.11.4263-4270.2004","article-title":"Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa","volume":"48","author":"Kruger","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib33","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/JCM.43.3.1072-1075.2005","article-title":"Extended-spectrum beta-lactamase-producing Shiga toxin gene (Stx1)-positive Escherichia coli O26:H11: a new concern","volume":"43","author":"Ishii","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib34","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1128\/JCM.42.11.5264-5269.2004","article-title":"Occurrence of extended-spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea","volume":"42","author":"Kim","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib35","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1128\/AAC.46.5.1462-1468.2002","article-title":"Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina","volume":"46","author":"Petroni","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3201\/eid0703.017313","article-title":"Third-generation cephalosporin resistance in Shigella sonnei, Argentina","volume":"7","author":"Radice","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib37","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/JCM.43.6.2940-2943.2005","article-title":"Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended-spectrum beta-lactamases isolated from children with diarrhea in Uruguay","volume":"43","author":"Vignoli","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib38","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1128\/JCM.43.7.3237-3243.2005","article-title":"Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in Northern Taiwan attributable to production of CTX-M-14 and CMY-2 \u03b2-lactamases","volume":"43","author":"Li","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib39","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AAC.46.5.1269-1272.2002","article-title":"Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998","volume":"46","author":"Carattoli","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib40","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1001\/jama.284.24.3151","article-title":"Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase","volume":"284","author":"Dunne","year":"2000","journal-title":"JAM"},{"key":"10.1016\/j.ajic.2006.05.238_bib41","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM200004273421703","article-title":"Ceftriaxone-resistant salmonella infection acquired by a child from cattle","volume":"342","author":"Fey","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2006.05.238_bib42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/srin.2002.34693","article-title":"Klebsiella and Enterobacter: antibiotic resistance and treatment implications","volume":"17","author":"Bouza","year":"2002","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.ajic.2006.05.238_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy","volume":"115","author":"Chow","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajic.2006.05.238_bib44","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1086\/344178","article-title":"Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia Teaching Hospitals","volume":"35","author":"Levison","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1128\/JCM.40.1.123-127.2002","article-title":"BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae","volume":"40","author":"Sanders","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0163-4453(98)94171-8","article-title":"The molecular and clinical epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in a tertiary care hospital","volume":"36","author":"D'Agata","year":"1998","journal-title":"J Infect"},{"key":"10.1016\/j.ajic.2006.05.238_bib47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JCM.38.2.542-546.2000","article-title":"Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes","volume":"38","author":"Tzelepi","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.diagmicrobio.2004.11.009","article-title":"Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria","volume":"51","author":"Park","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib49","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/JCM.43.2.826-831.2005","article-title":"Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China","volume":"43","author":"Jiang","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib50","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1128\/AAC.48.8.3159-3161.2004","article-title":"High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns","volume":"48","author":"Pai","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib51","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1128\/JCM.43.10.5058-5064.2005","article-title":"SHV-type extended-spectrum beta-lactamase production is associated with reduced cefepime susceptibility in Enterobacter cloacae","volume":"43","author":"Szabo","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib52","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2165\/00003495-200464120-00007","article-title":"Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections","volume":"64","author":"Carson","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.ajic.2006.05.238_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-4781(98)00127-4","article-title":"Clinical applications of quinolones","volume":"1400","author":"Hooper","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajic.2006.05.238_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0732-8893(02)00441-8","article-title":"Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China","volume":"44","author":"Xiong","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1054\/drup.1998.0068","article-title":"Mechanisms of fluoroquinolone resistance","volume":"2","author":"Hooper","year":"1999","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ajic.2006.05.238_bib57","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Martinez-Martinez","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2006.05.238_bib58","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.47.7.2242-2248.2003","article-title":"Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China","volume":"47","author":"Wang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/AAC.49.1.71-76.2005","article-title":"Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe","volume":"49","author":"Mammeri","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jac\/dkg388","article-title":"Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase","volume":"52","author":"Rodriguez-Martinez","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib61","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.48.4.1295-1299.2004","article-title":"Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States","volume":"48","author":"Wang","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib62","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1073\/pnas.082092899","article-title":"Mechanism of plasmid-mediated quinolone resistance","volume":"99","author":"Tran","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajic.2006.05.238_bib63","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/JCM.38.3.1048-1052.2000","article-title":"Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability","volume":"38","author":"Bornet","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1128\/jcm.31.1.123-127.1993","article-title":"Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem","volume":"31","author":"de Champs","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jac\/28.4.499","article-title":"Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes","volume":"28","author":"Chow","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","article-title":"Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae","volume":"48","author":"Poirel","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib67","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1128\/AAC.43.7.1669","article-title":"Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae","volume":"43","author":"Martinez-Martinez","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib68","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/AAC.41.3.563","article-title":"Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein","volume":"41","author":"Bradford","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib69","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/JCM.43.1.516-519.2005","article-title":"First isolation of metallo-beta-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil","volume":"43","author":"Lincopan","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib70","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1128\/JCM.41.8.3893-3896.2003","article-title":"VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals","volume":"41","author":"Giakkoupi","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib71","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JCM.39.12.4433-4439.2001","article-title":"Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan","volume":"39","author":"Yan","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib72","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1128\/AAC.45.6.1939-1940.2001","article-title":"Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 beta-lactamase and lacking an outer membrane protein","volume":"45","author":"Koh","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib73","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/jac\/dki073","article-title":"Characterization of a new integron containing bla(VIM-1) and aac(6\u2032)-IIc in an Enterobacter cloacae clinical isolate from Greece","volume":"55","author":"Galani","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib74","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/JCM.43.1.494-496.2005","article-title":"Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates","volume":"43","author":"Giakkoupi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.238_bib75","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib76","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jac\/dkg124","article-title":"Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates","volume":"51","author":"Smith Moland","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/421495","article-title":"Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City","volume":"39","author":"Bradford","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.238_bib78","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/AAC.48.12.4793-4799.2004","article-title":"Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center","volume":"48","author":"Woodford","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib79","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium","volume":"165","author":"Bratu","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajic.2006.05.238_bib80","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/AAC.49.7.3018-3020.2005","article-title":"Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection","volume":"49","author":"Bratu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib81","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1128\/AAC.49.2.776-778.2005","article-title":"Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York","volume":"49","author":"Bratu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dki175","article-title":"Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents","volume":"56","author":"Bratu","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.238_bib83","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1128\/AAC.47.4.1297-1300.2003","article-title":"Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2","volume":"47","author":"Miriagou","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655306008534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655306008534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:28:34Z","timestamp":1759296514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655306008534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0196655306008534"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2006.05.238","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance in gram-negative bacteria: Enterobacteriaceae","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2006.05.238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Association for Professionals in Infection Control and Epidemiology, Inc. and Elsevier, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}